Jirasiritham, S <br/><br/>
The role of anti-IL-2 receptor in high-risk kidney transplant patients.  [electronic resource] 

 -  Transplantation proceedings  Sep 2004 
 - 2110-2 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0041-1345 
<br/><br/><label>Standard No.: </label>10.1016/j.transproceed.2004.08.088  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Basiliximab<br/>Daclizumab<br/>Disease-Free Survival<br/>Female<br/>Follow-Up Studies<br/>Graft Rejection--epidemiology<br/>Graft Survival--immunology<br/>Histocompatibility Testing<br/>Humans<br/>Immunoglobulin G--therapeutic use<br/>Immunosuppressive Agents--therapeutic use<br/>Kidney Transplantation--immunology<br/>Living Donors<br/>Male<br/>Receptors, Interleukin-2--antagonists & inhibitors<br/>Recombinant Fusion Proteins--therapeutic use<br/>Reoperation--statistics & numerical data<br/>Retrospective Studies<br/>Spouses<br/>Survival Analysis<br/>Thailand<br/>Time Factors